NHS Saves £100 Million through Safer, Lower Cost Prescriptions

GPs and community providers across England have surpassed £100 million in directly attributable savings since frontline staff began using an innovative technology to prescribe less expensive and more clinically appropriate medicines for individual patients, it has been revealed today.

First introduced into the NHS in 2014 the medicines optimisation solution, called OptimiseRx, is now used in thousands of GP practices, and more than 125 of England’s 195 clinical commissioning groups (CCGs) have implemented the solution. It prompts doctors with messages when more cost-effective or clinically appropriate medications are available and makes patient-specific recommendations based on the patient’s medical record and clinical best practice.

A review of system usage across England, conducted by FDB (First Databank), found that £100 million of savings have been achieved by many thousands of prescribers selecting medicines suggested by the solution.

Phil Verplancke, Head of Product Management at FDB, the company behind the technology, said: "It's great news for the NHS that CCGs are making prescribing budget savings by allowing frontline staff to make the most of technology. However, the solution is more than saving money, and when you factor in the enormous health benefits and non-cash realisable savings that safer prescribing and best practice can bring, such as avoided hospital admissions, the overall benefit to the NHS and patients is likely to be even greater."

NHS Ipswich and East Suffolk CCG has made the highest saving of any CCG in the country. Rifat Choudhury, Medicines Management Pharmacist, NHS Ipswich and East Suffolk CCG, said: "FDB OptimiseRx has become a powerful tool that our medicines management team rely on to ensure that patient care is optimal, safe and in line with our local governance framework and drug formulary. Our general practice staff work incredibly hard to select the best possible medication and treatment choice for our patients, and OptimiseRx gives us the added ability of always promoting the most clinically appropriate and cost-effective choice based on fluctuating drug tariffs."

At peak times OptimiseRx supports more than 1 million prescribing transactions each day for the GP practices, out of hours clinics, and community care settings it serves.

It integrates directly with existing primary care clinical systems, including EMIS Web, TPP SystmOne and Microtest Evolution. This means that busy healthcare professionals are able to receive and act on alerts without logging in and out of multiple clinical systems.

The technology includes thousands of patient-specific algorithms that respond to clinically coded information in the patient record, and is still the only solution supporting medicines management teams with this level of patient specificity. This means that a patient's medical history, co-morbidities, existing drug regimen, and diagnostic results are considered in messages sent to prescribers. National guidance from NHS England and best practice guidance from organisations including NICE and the MHRA are also taken into account, with information then linked to the latest cost of pharmaceutical products in the market, and details of which medicines are approved for prescription locally.

Data from FDB customers also revealed that there is typically a less expensive alternative in around one in four patient consultations.

About FDB

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.

About FDB OptimiseRx

FDB OptimiseRx ™ is the leading medicines optimisation solution for primary care in the UK. OptimiseRx combines evidence-based best practice, safety and cost-effective prescribing messages, and delivers them in real time at the point of care during the prescribing workflow.

Used across more than 125 NHS Clinical Commissioning Groups (CCGs) and Health Boards and thousands of GP practices, OptimiseRx is trusted and valued by prescribers. OptimiseRx is the only solution that delivers patient-specific prescribing guidance, integrated with prescribing workflows, supporting medicines optimisation at the point of care in EMIS Web, TPP SystmOne and Microtest Evolution. Tailored to the patient medical record, OptimiseRx takes into consideration current and previous medications, morbidities, observations and measurements to support prescribers to make the safest, most clinically appropriate prescribing decision.

Most Popular Now

Open Call HORIZON-HLTH-2021-TOOL-06-03: …

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 "Unlocking the full potential of new tools, technologies and digital...

CSAM Acquires Optima - Further Boosts eH…

CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from...

Novartis and Hewlett Packard Enterprise …

Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to...

COVID-19 Origins Still a Mystery

Scientists using computer modelling to study SARS-CoV-2, the virus that caused the COVID-19 pandemic, have discovered the virus is most ideally adapted to infect human cells - rather than bat...

Using Artificial Intelligence to Overcom…

Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence. Now...

Deep Machine Learning Completes Informat…

The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity information for a million molecules using deep machine-learning computational models. It has...

EU Digital COVID Certificate Enters into…

The EU Digital COVID Certificate Regulation enters into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across...

Philips and the Spanish National Center …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique [1,2] that could...

Scottish Health and Care Professionals G…

Scottish health and care professionals across a wide range of clinical settings including NHS Scotland health boards are being given access to an individual's COVID-19 vaccine status through the Orion...

Ethics and Governance of Artificial Inte…

Artificial Intelligence (AI) refers to the ability of algorithms encoded in technology to learn from data so that they can perform automated tasks without every step in the process having...

It's Going to be Quite a Handover…

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it...

Philips Accelerates Stroke Diagnosis and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke...